DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart Lung and Blood Institute
RESEARCH AGENDA ON COMPLICATIONS OF HEMOPHILIA
AND OTHER BLEEDING DISORDERS
Harold Varmus, M.D.
Director, NIH
April, 1999
The complete report
is available in one PDF file (67 K), which
is ideal for printing and reading off-line. Information on
Adobe's PDF file is also available.
EXECUTIVE SUMMARY
INTRODUCTION
BACKGROUND
-
- Treatment of Hemophilia and Other Bleeding Disorders
- Improvements in Blood Safety
- Complications of Hemophilia
- Complications of Other Bleeding Disorders
- Finding a Cure
RESEARCH ON COMPLICATIONS
OF HEMOPHILIA
-
- Mechanisms of Bleeding and Clotting
- Antibody/Inhibitor Formation
- Gene Therapy for Hemophilia
- Blood-Borne Infectious Agents
- Human Immunodeficiency Virus (HIV)
Hepatitis C Virus (HCV)
- Blood Safety
- HIV and Hepatitis
Creutzfeldt-JakobDisease(CJD)
- Behavioral Research
MONITORING THE BLOOD SUPPLY
COORDINATING COMMITTEES
-
- Public Health Service (PHS) Blood Safety Committee
- DHHS Advisory Committee on Blood Safety and Availability
(ACBSA)
- Trans-Angency Hepatitis Working Group
- Trans-NIH Hepatitis C Virus Working Group
- Other Coordinating Groups
CONCLUSION
8/31/99 |